Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Leverage Shares PLC 24 April 2023 Leverage Shares plc 24 April 2023 THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF THE HOLDERS OF THE ETP SECURITIES. IF ANY ETP SECURITYHOLDER...
NASDAQ: CRME TSX: COM VANCOUVER, Dec. 21 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRMENASDAQ:/NASDAQ:TSX:NASDAQ:COM) today announced that it has amended its Disclosure Policy to...
NASDAQ: CRME TSX: COM VANCOUVER, Dec. 17 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRMENASDAQ:/NASDAQ:TSX:NASDAQ:COM) today announced that the recently-completed Phase 3 European...
NASDAQ: CRME TSX: COM VANCOUVER, Nov. 9 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRMENASDAQ:/NASDAQ:TSX:NASDAQ:COM) today reported financial results for the third quarter ended...
NASDAQ: CRME TSX: COM VANCOUVER, Nov. 6 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRMENASDAQ:/NASDAQ:TSX:NASDAQ:COM) today announced that it will report financial results for the...
NASDAQ: CRME TSX: COM VANCOUVER, Nov. 2 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRMENASDAQ:/NASDAQ:TSX:NASDAQ:COM) today announced that Doug Janzen, President and CEO, is...
NASDAQ: CRME TSX: COM VANCOUVER and DEERFIELD, IL, Oct. 28 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ:CRME/TSX:NASDAQ:COM) and its co-development partner Astellas Pharma US, Inc...
NASDAQ: CRME TSX: COM VANCOUVER, Oct. 16 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRMENASDAQ:/NASDAQ:TSX:NASDAQ:COM) ("Cardiome" or the "Company") announced the final results of...
NASDAQ: CRME TSX: COM VANCOUVER, Oct. 14 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRME/TSX:NASDAQ:COM) ("Cardiome" or the "Company") announced the preliminary results of its...
NASDAQ: CRME TSX: COM VANCOUVER, Sept. 1 /PRNewswire-FirstCall/ -- Cardiome Pharma Corp. (NASDAQ: CRME/TSX:NASDAQ:COM) ("Cardiome" or the "Company") announced that it has mailed an offer to...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | SP |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
